DexCom (NASDAQ:DXCM) Downgraded to Hold at StockNews.com

StockNews.com downgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a buy rating to a hold rating in a report issued on Thursday morning. A number of other analysts have also commented on DXCM. Barclays lifted their target price on shares of DexCom from $110.00 to $115.00 in a report on Monday, May 1st. Citigroup […]

Related Keywords

United States ,Jacob Steven Leach ,Jeremem Sylvain ,Morgan Stanley ,Nasdaq ,Dexcom Inc ,Geode Capital Management ,Hermes Inc ,Dexcom Company Profile ,Norges Bank ,Securities Exchange Commission ,Pricet Rowe Associates Inc ,Citigroup ,Barclays ,Jennison Associates ,Free Report ,Moderate Buy ,Get Free Report ,Exchange Commission ,Steven Leach ,Capital Management ,Federated Hermes ,Dexcom Share ,Dexcom Real Time ,Dexcom Daily ,Dexcom ,Nasdaq Dxcm ,Dxcm ,Medical ,25213110 ,Downgrade ,Stocknews Com ,